TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3838352

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30552078

Group type: EXPERIMENTAL
Intervention: Eltern als Therapeuten (E@T)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 66
Study: 26348685

Group type: EXPERIMENTAL
Intervention: Web group (access to Web-based information)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group (no scheduled contact)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Phone group (2 scheduled phone contacts)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Web group
Number of subjects: 235

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 235

Group type: COMPARATOR
Intervention: Phone group
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Relapses, fecal incontinence, and laxative use
Number of subjects: 235
Study: 24525654

Group type: EXPERIMENTAL
Intervention: Sertraline (200 mg/d)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sertraline plus Gabapentin (SERT + GBP)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 99
Study: 22068016

Group type: EXPERIMENTAL
Intervention: Strawberry powder (equivalent to four servings of frozen strawberries)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (strawberry-flavoured intervention)
Number of subjects: 20
Study: 20018493

Group type: EXPERIMENTAL
Intervention: 50mg/d LY686017
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: 20mg/d paroxetine
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 18544577

Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 466

Group type: COMPARATOR
Intervention: Slow freezing
Number of subjects: 466
Study: 15922814

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 2696

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 2696

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2696

Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg and 100 mg
Number of subjects: 2696
Study: 15643749

Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/xylitol chewing gum
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Sodium fluoride chewing gum
Number of subjects: 173

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 173
Study: 10626291

Group type: EXPERIMENTAL
Intervention: LH-RH agonist leuprorelin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytotoxic agent treosulfane
Number of subjects: 0

Group type: COMPARATOR
Intervention: LH-RH agonists in conventional doses
Number of subjects: 0
Study: 8848781

Group type: EXPERIMENTAL
Intervention: Tailored dietary information and instruction by a clinical nutritionist
Number of subjects: 49

Group type: COMPARATOR
Intervention: Regular dietary information from a nurse
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Intensive dietary information (in-patients)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Out-patients
Number of subjects: 49
Study: 1298616

Group type: EXPERIMENTAL
Intervention: Anal dilatation
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Posterior internal sphincterotomy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lateral sphincterotomy
Number of subjects: 78
Study: 6232015

Group type: EXPERIMENTAL
Intervention: 4.0 x 10(6) units of procaine penicillin plus 1 g of probenecid
Number of subjects: 460

Group type: COMPARATOR
Intervention: 2 g of spectinomycin
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Penicillin treatment
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Spectinomycin treatment
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Tetracycline (as second-line treatment)
Number of subjects: 460
Study: 31622397

Group type: EXPERIMENTAL
Intervention: ASPIRE (smoking prevention interactive experience)
Number of subjects: 110
Study: 28086813

Group type: EXPERIMENTAL
Intervention: Presence of an opinion leader for CVRM
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for SBP targets
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for LDL targets
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for SBP targets in specific information networks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low homophily on positive attitudes for LDL targets in specific information networks
Number of subjects: 180
Study: 25939115

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) insomnia regimen
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 23097326

Group type: EXPERIMENTAL
Intervention: Lateral foot wedging (prescribed laterally wedged foot orthoses)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Neutral orthoses (control group)
Number of subjects: 38
Study: 22048225

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis inhalation (3 times a day on days 2-4 and in the morning of day 5)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sustained-release morphine or oxycodone (control group)
Number of subjects: 21
Study: 19567545

Group type: EXPERIMENTAL
Intervention: Normothermic CPB (35‐37 degrees C)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hypothermic CPB (28‐30 degrees C)
Number of subjects: 50
Study: 16485224

Group type: EXPERIMENTAL
Intervention: Blepharochalasis operation for cosmetic reasons (group 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Blepharochalasis operation for medical reasons (group 2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tear secretion measurement by Schirmer's test and break-up time
Number of subjects: 32
Study: 15259908

Group type: EXPERIMENTAL
Intervention: IL-2
Number of subjects: 12

Group type: COMPARATOR
Intervention: HAART alone
Number of subjects: 12
Study: 11677339

Group type: EXPERIMENTAL
Intervention: Laparoscopic bipolar coagulation of uterine vessels with LUNA (group A)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Laparoscopic bipolar coagulation of uterine vessels only (group B)
Number of subjects: 85
Study: 10216646

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 99

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 99
Study: 7875191

Group type: COMPARATOR
Intervention: ramipril + placebo (R+P)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ramipril + simvastatin (R+S)
Number of subjects: 22
Study: 3313202

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipipanone 8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indomethacin (both doses)
Number of subjects: 0
Study: 29921255

Group type: EXPERIMENTAL
Intervention: Extensive intervention (coaching sessions by occupational health physicians using motivational interviewing)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Limited intervention (web-based Health Risk Assessment with advice)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Both interventions (Extensive and Limited)
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Extensive intervention
Number of subjects: 491

Group type: COMPARATOR
Intervention: Limited intervention
Number of subjects: 491
Study: 27621602

Group type: EXPERIMENTAL
Intervention: Immediate pedometer use with goal setting
Number of subjects: 130

Group type: COMPARATOR
Intervention: Delayed pedometer use
Number of subjects: 130
Study: 25765670

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 104
Study: 24204003

Group type: EXPERIMENTAL
Intervention: Low sodium intake
Number of subjects: 20
Study: 21817806

Group type: EXPERIMENTAL
Intervention: Intensive therapy (IT) aiming for BP < 120/80 mm Hg and LDL-C < 80 mg/dl
Number of subjects: 498

Group type: COMPARATOR
Intervention: Conventional therapy (CT) aiming for BP < 140/90 mm Hg and LDL-C < 100 mg/dl
Number of subjects: 498
Study: 19702078

Group type: EXPERIMENTAL
Intervention: Shenfu Injection (SFI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 17229605

Group type: EXPERIMENTAL
Intervention: Emedastine difumarate (2 mg b.i.d.)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Loratadine (10 mg o.d.)
Number of subjects: 192
Study: 12843002

Group type: COMPARATOR
Intervention: Mercaptopurine (MP)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Thioguanine (TG)
Number of subjects: 521
Study: 10934673

Group type: EXPERIMENTAL
Intervention: rhIL-11 (25 micrograms/kg s.c. once daily)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: rhIL-11 + Maxzide-25 (25 micrograms/kg s.c. once daily + Maxzide-25 twice daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9113841

Group type: EXPERIMENTAL
Intervention: Community based childhood injury prevention program providing education and safety supplies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education and promotion of proper use of child restraint systems in automobiles
Number of subjects: 0
Study: 7902092

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 2883132

Group type: EXPERIMENTAL
Intervention: Levocabastine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 29503129

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 636

Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Failure to complete preoperative chemotherapy
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Splenectomy
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Oesophago‐cardia resection
Number of subjects: 636
Study: 27562409

Group type: EXPERIMENTAL
Intervention: Lung-protective ventilation with tidal volume 6 ml/kg and PEEP 5 cmH2O (group L)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard ventilation with tidal volume 10 ml/kg and PEEP 0 cmH2O (group S)
Number of subjects: 66
Study: 25287779

Group type: EXPERIMENTAL
Intervention: GAME intervention (goal-oriented motor training and enrichment intervention programme)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GAME intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard community based care (control)
Number of subjects: 30
Study: 22920402

Group type: EXPERIMENTAL
Intervention: Cylindrical abdominoperineal resection (APR)
Number of subjects: 67
Study: 21215201

Group type: EXPERIMENTAL
Intervention: Gasless endoscopic thyroidectomy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional thyroidectomy
Number of subjects: 47
Study: 18272140

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment for 4 weeks
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 51
Study: 16517559

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone treatment (20 microg/kg per day) for 5 days before gonadotrophin treatment
Number of subjects: 25
Study: 12918077

Group type: EXPERIMENTAL
Intervention: Current oral contraceptive use
Number of subjects: 10514

Group type: COMPARATOR
Intervention: Oral contraceptive use
Number of subjects: 10514
Study: 11139006

Group type: EXPERIMENTAL
Intervention: Stressed group (prepared a 4-minute speech)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (listened to a passage of neutral text)
Number of subjects: 68
Study: 9105223

Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 13
Study: 8248274

Group type: EXPERIMENTAL
Intervention: Fish oil as adjunctive therapy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 2863492

Group type: EXPERIMENTAL
Intervention: Intravenous IgG
Number of subjects: 108

Group type: COMPARATOR
Intervention: Oral corticosteroids
Number of subjects: 108
Study: 31109356

Group type: EXPERIMENTAL
Intervention: Tamponade dressings
Number of subjects: 0

Group type: COMPARATOR
Intervention: No tamponade
Number of subjects: 0
Study: 28495197

Group type: COMPARATOR
Intervention: Allopurinol 10 mg/kg PO BID for 180 days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: AHCC 17 mg/kg plus nucleotides 32 mg/kg PO SID for 180 days
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both treatments (Allopurinol and Supplement)
Number of subjects: 69
Study: 25401419

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 23613362

Group type: EXPERIMENTAL
Intervention: Patient-centered educational intervention (decision-aid video with or without brief counseling)
Number of subjects: 639

Group type: EXPERIMENTAL
Intervention: Any intervention (decision-aid video with or without brief counseling)
Number of subjects: 639
Study: 21713735

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 19027357

Group type: EXPERIMENTAL
Intervention: Anodal TDCS
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cathodal TDCS
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham TDCS
Number of subjects: 21
Study: 16436132

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) combined with ribavirin and interleukin-2 (IL-2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Interferon-alpha (IFN-alpha) combined with ribavirin
Number of subjects: 20
Study: 15070596

Group type: EXPERIMENTAL
Intervention: Cytoreduction and HIPEC
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Second surgical debulking for recurrent disease
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Chemotherapy for recurrent disease
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Radiotherapy for recurrent disease
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: No further treatment
Number of subjects: 106
Study: 10907210

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 24
Study: 9310511

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with HF-OPT
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 130
Study: 7871050

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 and 0.5 mg/70 kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temazepam (60 mg/70 kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg/70 kg)
Number of subjects: 0
Study: 2936877

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 30690879

Group type: COMPARATOR
Intervention: Dietary polyphenols and methylxanthines (pomegranate, orange, lemon, olive, cocoa, and grapeseed extracts plus resveratrol) consumed as three capsules daily for 6 ± 2 days, providing 473.7 mg of phenolics and 19.7 mg of theobromine and caffeine.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (8 patients) did not consume extracts.
Number of subjects: 19
Study: 29187901

Group type: EXPERIMENTAL
Intervention: First-line platinum-based doublet chemotherapy
Number of subjects: 52
Study: 25450208

Group type: EXPERIMENTAL
Intervention: Sofosbuvir 400mg and weight-based ribavirin for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sofosbuvir 400mg and weight-based ribavirin for 24 weeks
Number of subjects: 60
Study: 23177415

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation in culture medium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-supplemented control group
Number of subjects: 0
Study: 21860990

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-intervention control group
Number of subjects: 42
Study: 19224814

Group type: EXPERIMENTAL
Intervention: 8% lidocaine pump spray (Xylocaine pump spray, XPS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Saline placebo pump spray
Number of subjects: 31
Study: 17035563

Group type: EXPERIMENTAL
Intervention: Telephone care management program (3 sessions)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 207
Study: 12488372

Group type: EXPERIMENTAL
Intervention: COPA without fentanyl pretreatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: LMA without fentanyl pretreatment
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: COPA with fentanyl pretreatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: LMA with fentanyl pretreatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo group with both devices
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both devices (COPA and LMA)
Number of subjects: 75
Study: 11114680

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis in lactose-hydrolysed low-fat milk (LFM)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis in low-fat milk (LFM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Reconstituted low-fat milk (LFM)
Number of subjects: 50
Study: 8895037

Group type: EXPERIMENTAL
Intervention: Blackcurrant seed oil (BSO) 6 g daily for 8 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Safflower oil 6 g daily for 8 weeks
Number of subjects: 27
Study: 1803595

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate aerosol
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 6643842

Group type: EXPERIMENTAL
Intervention: Noise fluctuation achieved by modulating a wide band of noise (experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Narrowing the noise bandwidth (experiment 2)
Number of subjects: 0
Study: 30610026

Group type: EXPERIMENTAL
Intervention: Renal hypothermia during open partial nephrectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warm ischaemia (no renal hypothermia)
Number of subjects: 0
Study: 29395637

Group type: EXPERIMENTAL
Intervention: D + Ca + B (1200 IE vitamin D3, 800 mg Ca-carbonate, 0.5 mg B9, 50 mg B6, 0.5 mg B12)
Number of subjects: 63

Group type: COMPARATOR
Intervention: D + Ca (1200 IE vitamin D3, 800 mg Ca-carbonate)
Number of subjects: 63
Study: 26294207

Group type: EXPERIMENTAL
Intervention: Ornipressin (Por‐8, Ferring) solution
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 80
Study: 24500582

Group type: EXPERIMENTAL
Intervention: Patellar eversion
Number of subjects: 68

Group type: COMPARATOR
Intervention: Patellar subluxation
Number of subjects: 68
Study: 23082707

Group type: EXPERIMENTAL
Intervention: Colpermin (peppermint oil capsules)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 20102596

Group type: EXPERIMENTAL
Intervention: McKenzie method in addition to first-line care (advice, reassurance, and time-contingent acetaminophen)
Number of subjects: 148

Group type: COMPARATOR
Intervention: First-line care alone
Number of subjects: 148
Study: 18094892

Group type: EXPERIMENTAL
Intervention: Supervised pelvic floor muscle exercises
Number of subjects: 44

Group type: COMPARATOR
Intervention: Unsupervised pelvic floor muscle exercises
Number of subjects: 44
Study: 15322767

Group type: EXPERIMENTAL
Intervention: SPM (Statistical Parametric Mapping)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: NS (NEUROSTAT)
Number of subjects: 20
Study: 12163810

Group type: EXPERIMENTAL
Intervention: Recombinant human activated protein C (rhAPC)
Number of subjects: 0
Study: 10502624

Group type: EXPERIMENTAL
Intervention: Starch based hot stage extrusion formulation containing 300 mg anhydrous theophylline
Number of subjects: 8

Group type: COMPARATOR
Intervention: Commercially available multiple unit sustained release product
Number of subjects: 8
Study: 8604729

Group type: EXPERIMENTAL
Intervention: 0.5% timolol solution (administered twice daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 0.5% timolol gellan (administered once daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 1916557

Group type: EXPERIMENTAL
Intervention: Hydrotalcit (aluminium‐magnesium hydroxide carbonate hydrate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6276746

Group type: COMPARATOR
Intervention: Calcium (with or without vitamin D)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Sodium fluoride combined with conventional therapy
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Estrogen and calcium (with or without vitamin D)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Fluoride, estrogen, and calcium (with or without vitamin D)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Fluoride (one year of treatment)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Combination of calcium, fluoride, and estrogen
Number of subjects: 165
Study: 31138725

Group type: EXPERIMENTAL
Intervention: Docetaxel 50 mg/m2, Oxaliplatin 85 mg/m2, 5-FU 2400 mg/m2 continuous intravenous infusion over 46 hours, cycles every 2 weeks
Number of subjects: 44
Study: 27546475

Group type: EXPERIMENTAL
Intervention: Reflective blankets
Number of subjects: 50

Group type: COMPARATOR
Intervention: Forced air warming devices
Number of subjects: 50
Study: 27554525

Group type: EXPERIMENTAL
Intervention: KNW self-management intervention
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Module referral advice
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Having a partner
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Perceived personal relevance
Number of subjects: 231
Study: 24445878

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia (target mean arterial pressure of 50 mm Hg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard anesthesia (target mean arterial pressure of 60 mm Hg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hypotensive anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard anesthesia
Number of subjects: 100